MedPath

Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)

Completed
Conditions
Quality of Life
Hypoparathyroidism
Interventions
Other: Non-interventional study
Registration Number
NCT04053647
Lead Sponsor
Nantes University Hospital
Brief Summary

Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. The hypothesis of the investigators is that the mental health is impaired in hypoparathyroid patients compared with thyroidectomized patients without hypoparathyroidism. The investigators evaluated the quality of life using the SF-36 survey in comparison with a control population of patients thyroidectomized but free from this complication. The voice quality, the cardiovascular risk, the kidney function and the incidence of urinary lithiasis were also evaluated.

Detailed Description

Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. In this retrospective, observational, multicentre study, the investigators evaluated the quality of life using the SF-36 survey in comparison with a control population of patients thyroidectomized but free from this complication. Patients in six centers in France (Angers, Le Mans, Limoges, Nancy, Nantes, la Pitié-Salpétrière) and in the association "Hypoparathyroïdisme France" were contacted by mail. The primary endpoint was the mental health. The physic and global quality of life scores were assessed as secondary endpoints. Medical and VHI surveys were also send to the patients. The voice quality, the cardiovascular risk, the kidney function and the incidence of urinary lithiasis were also evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
143
Inclusion Criteria
  • Patients operated of total thyroidectomy
  • Patients suffering from persistent hypoparathyroidism defined as serum PTH inferior to 15 pg/mL 6 months after the surgery, requiring vitamin-calcic supplementation.
  • Age superior to 18
  • Answering the survey
Exclusion Criteria
  • Pregnancy at the time of the study
  • Age inferior to 18 or adult under guardianship
  • Patients with vitamino-calcic supplementation without serum PTH measurement
  • Cause of hypoparathyroidism other than post-operatory.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Hypoparathyroid patientsNon-interventional studyPatients with persistent hypoparathyroidism after total thyroidectomy, defined as serum PTH inferior to 15 pg/mL 6 months after surgery and the need of vitamin-calcic supplementation.
Control patients, without hypoparathyroidismNon-interventional study-
Primary Outcome Measures
NameTimeMethod
Mental healthThrough study completion, an average of 1 year

Items from mental quality of life score defined by the SF36 (Short Form 36) survey

Secondary Outcome Measures
NameTimeMethod
Physical quality scoreThrough study completion, an average of 1 year

Items from the SF36 (Short Form 36) survey

Renal function qualityThrough study completion, an average of 1 year

Serum creatinine and clearance dosage

Presence of urinary lithiasisThrough study completion, an average of 1 year

Serum creatinine and clearance dosage

Voice qualityThrough study completion, an average of 1 year

Items from the VHI (Voice Handicap Index) survey

Global quality of life scoreThrough study completion, an average of 1 year

Items from the SF36 (Short Form 36) survey

Presence of cardiovascular complicationsThrough study completion, an average of 1 year

Defined as ischemic cardiopathy

Trial Locations

Locations (6)

Centre Hospitalier Le Mans

🇫🇷

Le Mans, France

CHU Angers

🇫🇷

Angers, France

CHU Limoges

🇫🇷

Limoges, France

CHU Nancy

🇫🇷

Nancy, France

CHU Nantes

🇫🇷

Nantes, France

AP-HP La Pitié Salpétrière

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath